Back to BCRX
Assenagon Asset Management S.A. → BCRX
Assenagon Asset Management S.A. BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$3.7M
Q3 2026
Peak value
$23.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $23.5M |
| Q4 2025 | $2.8M |
| Q1 2026 | $2.2M |
| Q2 2026 | $3.5M |
| Q2 2026 | $3.5M |
| Q3 2026 | $3.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.7M | 449.1K | — | — |
| Q2 2026 | $3.5M | 353.0K | — | — |
| Q2 2026 | $3.5M | 353.0K | — | — |
| Q1 2026 | $2.2M | 232.9K | — | — |
| Q4 2025 | $2.8M | 359.6K | — | — |
| Q3 2025 | $23.5M | 3.09M | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M